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Mutations in the mitochondrial genome are associated with a wide range of neurological symptoms, but many aspects of the
basic neuronal pathology are not understood. One candidate mechanism, given the well-established role of mitochondria in
calcium buffering, is a deﬁcit in neuronal calcium homoeostasis. We therefore examined calcium responses in the neurons
derived from various ‘cybrid’ embryonic stem cell lines carrying different mitochondrial DNA mutations. Brief ( 50ms), focal
glutamatergic stimuli induced a transient rise in intracellular calcium concentration, which was visualized by bulk loading the
cells with the calcium dye, Oregon Green BAPTA-1. Calcium entered the neurons through N-methyl-D-aspartic acid and
voltage-gated calcium channels, as has been described in many other neuronal classes. Intriguingly, while mitochondrial muta-
tions did not affect the calcium transient in response to single glutamatergic stimuli, they did alter the responses to repeated
stimuli, with each successive calcium transient decaying ever more slowly in mitochondrial mutant cell lines. A train of stimuli
thus caused intracellular calcium in these cells to be signiﬁcantly elevated for many tens of seconds. These results suggest that
calcium-handling deﬁcits are likely to contribute to the pathological phenotype seen in patients with mitochondrial DNA
mutations.
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The pathological mechanisms underlying mitochondrial disease
are not understood, and yet there is increasing evidence of the
importance of these disorders. The prevalence of clinical disease
directly attributable to mitochondrial DNA mutations is in excess
of 1 in 10000 adults in the UK (Schaefer et al., 2008), while
a study of 3000 sequential births showed that pathogenic mito-
chondrial DNA mutations are present at surprisingly high levels
in the general population: one mitochondrial tRNA mutation,
the m.3243A>G MTTL1 gene mutation, was present at a
frequency of 0.14% (Elliott et al., 2008). Mitochondrial patho-
logy may also be involved in Alzheimer’s disease (Bender
et al., 2008), Parkinson’s disease (Bender et al., 2006), and in
normal brain ageing (Bender et al., 2006; Kraytsberg et al.,
2006), since all are associated with strikingly similar patterns of
mitochondrial abnormalities and mitochondrial respiratory chain
deﬁcient cells.
Neuronal dysfunction and neurodegeneration are the most
prominent and disabling features in patients with mitochondrial
disease (DiMauro and Davidzon, 2005; DiMauro and Schon,
2008). An enduring puzzle about these pathologies is the extreme
variability of presentation, ranging from focal deﬁcits (e.g. optic
neuropathy) to more global disease such as dementia and ataxia
(McFarland et al., 2007). To address this issue, it is necessary to
understand the basic pathological mechanisms. For instance,
neuronal loss is a common feature of these pathologies (Sparaco
et al., 1993), but it is possible that mitochondrial deﬁcits could
disrupt neuronal function even without neurodegeneration. These
different pathological processes would indicate different strategies
for treating or preventing the development of symptoms in
patients with mitochondrial disease. The pathology underlying
the various clinical presentations may thus be best served by
very different therapies.
One possible pathological mechanism may involve the
well-established role of mitochondria in regulating cytosolic Ca
2+
levels. Calcium ions lie at the heart of neuronal function, trans-
ducing electrical activity into molecular signals. The speciﬁcity
of the molecular response is thought to be set by the kinetics
and localization of the Ca
2+ transients (Berridge et al., 2003).
Altered cytosolic Ca
2+ regulation may also cause cells to enter
into various cell death pathways. Consequently, factors which
shape the Ca
2+ transients are likely to assume great importance
in normal neuronal function. A key role in this regard is played
by mitochondria. The large electrochemical gradient across
the mitochondrial inner membrane provides a powerful driving
force to absorb Ca
2+ from the cytosol (Vasington and Murphy,
1962; Carafoli et al., 1964; Crompton et al., 1978; Nicholls,
1978). Agents which uncouple the mitochondrial membrane
potential (Wm) prevent mitochondria from taking up Ca
2+,
and thus alter the time course of cytosolic Ca
2+ transients
(Werth and Thayer, 1994). The mitochondrial membrane potential
is generated by the electron transfer chain (Mitchell and
Moyle, 1967), but it is not known how subtle deﬁcits in the
electron transfer chain, caused by genetic mutations, might
impact on Ca
2+ homoeostasis in neurons. This information will be
critical for us to understand how such mutations cause neurological
disease.
Abnormal calcium homoeostasis has been reported in a variety
of non-neuronal cell lines with oxidative phosphorylation defects.
Fibroblasts from patients with m.3243A4G MTTL1 mutation
showed increased basal Ca
2+ levels and a sustained Ca
2+ elevation
in response to stimulation with 60mMK
+ compared with controls
(Moudy et al., 1995). Likewise, ﬁbroblasts from patients with
complex I deﬁciency due to nuclear subunit mutations also
showed a protracted period of elevated cytosolic Ca
2+ in response
to bradykinin (Visch et al., 2004, 2006; Willems et al., 2008).
Another approach to understanding how pathogenic mtDNA
mutations affect cellular Ca
2+ homoeostasis has been to generate
‘cybrid’ cell lines, by fusing enucleated somatic cells harbouring
pathogenic or neutral mtDNA mutations with a cell line in which
the endogenous mtDNA had been chemically ablated (a  
 
cell
line) (Brini et al., 1999). Cybrids derived from a patient with myo-
clonic epilepsy with ragged red ﬁbres due to the m.8356T4C
mutation showed no abnormality in cytosolic Ca
2+, but did show
a smaller than normal rise in mitochondrial Ca
2+ in response to
histamine (Brini et al., 1999). In contrast, cybrids from a patient
with the neuropathy, ataxia and retinitis pigmentosa m.8993T4G
mutation showed no Ca
2+ abnormality. Intriguingly, in both the
cybrid and ﬁbroblast cell lines with abnormal Ca
2+ responses,
near-normal Ca
2+ dynamics could be restored by inhibition of
mitochondrial sodium/calcium exchange by the benzothiopene
CGP37157 (Brini et al., 1999; Visch et al., 2004, 2006; Willems
et al., 2008). A notable feature of all these studies though is that
Ca
2+ deﬁcits in these cells are subtle.
Importantly however, there are currently no published studies of
Ca
2+ deﬁcits in neurons with mtDNA mutations, and yet the brain
is where the pathology has its major effect. Neuronal function
places unique demands on Ca
2+-handling pathways, and for this
reason, ﬁbroblast responses to G protein coupled receptor activa-
tion are likely to give only limited insights into how mtDNA muta-
tions might impact on brain function. For instance, the major
source of Ca
2+ entering the cytosol in neurons is from the
extracellular space through voltage-gated Ca
2+ channels [including
N-methyl-D-aspartic acid (NMDA) glutamate receptors], whereas
in non-neuronal cells, the major source is the endoplasmic reticu-
lum (Hille, 2002). Consequently, cytosolic Ca
2+ in neurons can rise
extremely quickly, and there is good evidence that the kinetics of
the Ca
2+ transient determine the cellular response (Nishiyama
et al., 2000). A further difference is that store operated Ca
2+
channels play a key role in Ca
2+ homoeostasis in many
non-neuronal cells, but not apparently in neurons. The recent
demonstration that store operated Ca
2+ channels are regulated
by mitochondria in a Ca
2+-dependent manner (Glitsch et al.,
2002; Parekh, 2003, 2008) suggests another way in which mito-
chondrial dysfunction may affect neuronal and non-neuronal cells
rather differently.
So far, neuronal mitochondrial studies have all used pharmaco-
logical agents to impair mitochondrial function, since fresh neuro-
nal material possessing mtDNA mutations is not readily available.
Neurosurgical biopsy is not indicated, either for diagnosis or
treatment, and attempts to generate sustainable transgenic mice
colonies carrying pathogenic mtDNA mutations have proven
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technology to generate mouse embryonic stem cell lines possess-
ing different pathogenic and benign mtDNA mutations (Kirby
et al., 2009). We showed previously that these embryonic
stem-derived cybrids could be differentiated into mature neurons,
which readily ﬁre action potentials and form synaptically con-
nected networks (Kirby et al., 2009). Our model system provides
the opportunity to examine Ca
2+ homoeostasis in neurons, the
most clinically affected tissues in oxidative phosphorylation
disorders.
We report here that in addition to their electrophysiological
phenotype, these differentiated stem cells also show a conven-
tional, transient Ca
2+ response to physiological activation by
glutamate. Surprisingly, cells possessing pathogenic mtDNA muta-
tions had a normal baseline response to glutamate. Repeated stim-
ulation, however, unveiled a progressive deﬁcit resulting in
markedly distorted Ca
2+ transients in response to later stimuli in
a train. We predict that these distorted Ca
2+ transients may be
misinterpreted by the various molecular transduction pathways,
leading to a loss or change in speciﬁcity of Ca
2+ signals.
Furthermore, the greatly protracted Ca
2+ transients in cell lines
containing pathogenic mtDNA mutations may also increase the
risk of triggering necrotic or apoptotic cell death (Clarke et al.,
1993; Hardingham et al., 2002). Thus, pathogenic mtDNA muta-
tions can cause changes in Ca
2+ regulation that can explain the
appearance of neuronal pathology with or without accompanying
neuronal cell death.
Materials and methods
Cell lines used in this study were described previously (Kirby et al.,
2009). All cybrids were derived from ES-I (CC9.3.1). Control cell lines
used for the calcium studies were the parental embryonic stem cell line
ES-I and a cybrid (Cy1-I) with a benign polymorphic variant
(m.9821Adel) in the mitochondrial transfer RNA for arginine (Mttr).
Cybrids with altered electron transfer chain function were Cy2-I and
Cy3-I. Cy2-I harbours the m.6589T4C mutation in one of the three
mtDNA encoded complex IV subunits (Mtco1) and has a mild complex
IV deﬁcit ( 40% residual complex IV activity). Cy3-I has two muta-
tions, in different mtDNA encoded complex I subunits (m.13887Cins in
Mtnd6 and m.12273G4Ai nMtnd5) and has a severe complex I
defect (510% residual complex I activity).
Differentiation into neurons
Parental embryonic stem cells and cybrids were differentiated into
neurons using the 4+/4  method (Bain et al., 1995) as described in
Kirby et al. (2009). Cultures were maintained on poly-D-lysine/laminin
coated coverslips. Calcium studies were performed on differentiated
neurons 7–9 days post-plating.
Dye loading
Cultures were bulk loaded with Oregon Green 488 BAPTA-1 (OGB1)-
acetoxymethyl ester as follows. OGB1-acetoxymethyl (50mg vial,
Molecular Probes) was mixed with 8ml dimethyl sulphoxide and 2ml
pluronic acid F-127 solution (10% in dimethyl sulphoxide, Molecular
Probes), and then further diluted by adding 90ml of culture media [4:1
medium: 4:1 mixture of Neurobasal medium (Invitrogen) supple-
mented with B27 (Invitrogen)] and Dulbecco’s modiﬁed Eagle’s
medium:F12 (1:1) (Invitrogen) supplemented with modiﬁed N2 (Ying
et al., 2003). Final mixture of 12–20ml was then added to the well
containing the culture plate bathed in 3ml of 4:1 medium. The ﬁnal
concentrations were OGB1-acetoxymethyl ester,  12mM; 0.1%
dimethyl sulphoxide; 0.002% Pluronic F-127. For the majority of
experiments, the cultures were incubated for 30–40min at 37 C and
then transferred to 4:1 medium without OGB1-acetoxymethyl for
20min at 37 C prior to transferring to the recording chamber. For
the control experiments using OGB2, the cultures were loaded up in
exactly the same way, only substituting OGB2-acetoxymethyl for
OGB1-acetoxymethyl.
To test the effect of changing dye concentrations, we performed
one set of experiments with variable loading times (Supplementary
Fig. S3). The coverslips, on which the cultures were grown, were
fractured using a diamond knife, and the dye was added to the
medium, and fragments of the coverslip were removed either at
30min, or after 1–2h loading. Imaging was performed after a
20min wash period for both.
Imaging
The recording chamber was mounted on an upright Zeiss Axioskop FS
microscope ﬁtted with Luigs and Neumann micromanipulators. Two
different imaging systems were used. The ﬁrst used epiﬂuorescence
illumination (standard ﬂuorescein ﬁlter blocks), with illumination con-
trolled by a Master 8 pulse stimulator (A.M.P.I., Jerusalem, Israel)
driving a Uniblitz shutter. Images were collected at 4Hz, using a
Hamamatsu camera connected to a Macintosh computer running
IPlab software. The second system used a spinning disc confocal
system (Visitech International, Sunderland, UK), collecting images at
up to 30Hz using a Hamamatsu C9100/13 EM charge-coupled device
camera and Visitech software run on a Dell personal computer.
Analysis was done ofﬂine using ImageJ (NIH, Bethesda), MATLAB
(Mathworks) and Igor (Wavemetrics, Oregon) software.
Electrophysiology
In the recording chamber, the cultures were bathed in a continuously
ﬂowing stream (1–3ml/min) of artiﬁcial CSF (in mM: NaCl, 125;
NaHCO3, 26; glucose, 10; KCl, 3.5; CaCl2, 1.2; NaH2PO4,
1.26; MgSO4, 1). Whole cell patch clamp recordings were made
using 5–7 MX pipettes (borosilicate glass, Harvard). The pipette solu-
tion contained (in milli molar) K-methylsulphate, 125; K-Hepes, 10;
Mg-ATP, 2.5; NaCl, 6; Na-GTP, 0.3 (corrected to pH 7.3–7.35 using
KOH; 280 mOsm). Data were collected using Axopatch 1D ampliﬁers
(Axon Instruments), ﬁltered at 3kHz, digitized at 5kHz (AD board)
and recorded on a Macintosh PowerMac computer using Axograph
software. Recordings were done at room temperature.
Glutamate application
Glutamate (1mM in artiﬁcial CSF) was applied directly from patch
pipettes using a picospritzer pressure application system (10ms
pulses; pressure=20psi). The timing of the pressure applications was
controlled using the Master 8 pulse stimulator. The pipette tip was
 10–50mm from the cells and, unless the pipette was broken, we
never detected any movement artefact during the glutamate applica-
tions, indicating that this means of stimulating cells was relatively
atraumatic. We discarded data if the pipette was broken. We calcu-
lated that the average bolus for a 10ms pressure application through
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extruded from the pipette over 1000 pressure pulses.
A23187 application
To assess the functional range of the Ca
2+ dye, we applied the Ca
2+
ionophore, A23187 (non-brominated form, also known as calcimycin;
Invitrogen) directly to the imaged cells using the same picospritz
method as for glutamate applications. External Ca
2+ concentration,
as for other experiments, was 2mM, the patch pipette A23187 con-
centration was 1mM and 10ms pressure pulses were applied at 10Hz
continually until the ﬂuorescence signal peaked ( 10–20s;
Supplementary movie 5).
Other drugs [NBQX, APV (both from Tocris, UK), NiCl2 and CdCl2
(both Sigma, UK)] were added to the entire bathing medium.
Results
Neuronal Ca
2+ transients triggered by
brief glutamatergic stimuli
We examined the neuronal responses to the excitatory neuro-
transmitter glutamate in differentiated neurons derived from
embryonic stem cell lines with different mitochondrial genotypes.
Speciﬁcally, we examined Ca
2+ transients in these cells, as assessed
by changes in ﬂuorescence in cells bulk labelled with the Ca
2+ dye,
OGB1. Our intention was to stimulate the cultures in a relatively
physiological way. To this end, we made brief glutamate applica-
tions at a concentration close to that found in the synaptic
cleft ( 1mM) (Clements et al., 1992). We delivered the gluta-
mate as a single, 10ms pressure puff (singlet), or a short train
of up to 10 puffs (each 10ms, delivered at between 1 and
0.1Hz), giving the cells adequate time between trials to
recover to baseline ﬂuorescence levels ( 2min for singlets, and
5–8min for longer trains). The time course of the picospritz stim-
ulus was visualized by ﬁlling the pipette with rhodamine and ima-
ging the ﬂuorescence change in front of the pipette (see
Supplementary movie 1). The half-width of the ﬂuorescence
pulse was  50ms, less than a single time frame (67ms; imaging
speed, 15Hz).
We recorded two distinct patterns of Ca
2+ transients in response
to brief glutamate applications (Fig. 1; Supplementary Movies 2
and 3). The ﬁrst pattern had slow kinetics, was very variable from
trial to trial, and consequently was not obviously time-locked to
the stimuli; cells showing this pattern were assumed to be
non-neuronal. The second, more common pattern was a rapidly
rising ﬂuorescence that occurred simultaneously in the soma and
all the extended cellular processes (beyond the temporal resolution
of the imaging at 4Hz). The responses were tightly locked to the
pressure pulse, and very reproducible over as many as 30 repeated
trials, indicating that this low rate of stimulation was indeed rea-
sonably physiological, producing very little, if any, deterioration in
any cell line. When these latter cells were targeted for patch clamp
recordings, they could always be driven to ﬁre action potentials,
thus conﬁrming their neuronal identity (Fig. 1B).
The glutamate applications induced a large inward current when
the cells were held at  70mV (Fig. 1A). The current decayed back
to baseline with a time constant of 1.35 0.92s (mean SD;
n=5; best ﬁt single exponential). Current clamp recordings
showed that this current strongly depolarized the cells, triggering
a barrage of action potentials riding on the crest of the
depolarization. The membrane potential also decayed slowly
(2.62 1.84s; best ﬁt single exponential). Electrophysiological
responses to picospritz glutamate applications were considerably
more prolonged than estimates of individual post-synaptic current
( psc=1.8ms; best ﬁt single exponential) or post-synaptic potential
decays ( psp=17.8ms; both measures averages of 3; best ﬁt single
exponential) (Kirby et al., 2009).
These different time courses provided insight into the level of
activation of glutamatergic receptors by the picospritz application.
The proﬁle of the rhodamine visualization of the picospritz event
(Fig. 1D and Supplementary movie 1) indicates a very brief gluta-
mate concentration peak (a few tens of milliseconds), while the
neuronal response clearly extends for a much longer period, far
longer than synaptic events in these cells (Kirby et al., 2009). This
suggests that for picospritz glutamate applications, the glutama-
tergic receptors continue to be activated long after the peak
glutamate concentration occurs, when the glutamate concentra-
tion has dropped to a fraction of the peak level. We can conclude
from this that these cultured neurons are responsive to levels of
glutamate considerably lower than 1mM (concentration of gluta-
mate within the pipette). Indeed, the uniform amplitude of the
electrophysiological events to successive stimuli (Supplementary
Fig. 1), in stark contrast to the incremental peaks in glutamate
concentration (Fig. 1F), strongly suggests that glutamatergic
receptors close to the puffer electrode were saturated, even
from the ﬁrst pulse (the rhodamine visualization of picospritzing
suggests that the ﬁrst pressure puff in a train produces a
smaller glutamate concentration—Fig. 1F—presumably because
of the diluting effect of diffusion of bath medium into the tip
during the period prior to the ﬁrst pressure pulse, which is
very long relative to the periods prior to subsequent pulses in a
train). Saturation of glutamatergic receptors may contribute to the
low variability of responses that we utilized in the later
experiments.
The Ca
2+ transient was about half an order of magnitude slower
than the current clamp responses (Table 1; best ﬁt single expo-
nential). Pharmacological analysis of the Ca
2+ transients (Fig. 2)
indicated that these relatively immature, cultured neurons had a
very conventional neuronal phenotype with regard to the source
of the increase in cytosolic Ca
2+. The signal was abolished by the
removal of extracellular Ca
2+, indicating that intracellular stores
make a negligible contribution to the transient signal. The signal
was greatly reduced by the selective NMDA antagonist APV
(50mM), indicating that a substantial current passes through
NMDA glutamatergic receptors. The residual signal was then abol-
ished either by blockade of  -amino-3-hydroxyl-5-methyl-4-isoxa-
zole-propionate (AMPA)/kainate glutamatergic receptors (10mM
NBQX), or by blockade of voltage-gated Ca
2+ channels (100mM
Ni
2+/100mMC d
2+). The fact that blockade of the voltage-gated
Ca
2+ channels in isolation reduced the signal by  80% suggests
that the major source of Ca
2+ was through these channels. The
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understood simply as a 2-fold effect, with a loss of Ca
2+ inﬂux
through these channels, and a reduced depolarizing drive also
leading to reduced Ca
2+entry through voltage-gated Ca
2+ chan-
nels. The simplest interpretation of these data is that exogenously
applied glutamate activates NMDA and AMPA/kainate receptors,
causing a large depolarization, and frequently triggering action
potentials, with Ca
2+ entering through both NMDA receptors
and voltage-gated Ca
2+ channels.
Subtle Ca
2+ kinetic phenotype in cells
with mitochondrial mutations
In all neuronal lines, the Ca
2+ response to a single brief application
of glutamate was variable from cell to cell (Fig. 3), suggestive
of heterogeneity within the populations. The Ca
2+ dye acts
as a weak buffer, and this can inﬂuence the decay kinetics
(Neher and Augustine, 1992; Sabatini et al., 2002), as evidenced
by the fact that extending the dye loading time caused
Figure 1 Neuronal responses to exogenously applied glutamate. (A–C) Different recording modes showing equivalent responses of a
neuron to 1mM glutamate delivered from a distance of about 25mm from a patch pipette subsequent to a 10ms pressure pulse applied to
the pipette. All three recording modes are shown at the same time scale for ease of comparison. The culture was bulk loaded with OGB1,
and the calcium response was recorded ﬁrst, prior to patching (whole cell patching causes the bulk-loaded dye to be washed out); this cell
had a robust and relatively constant (55% variability) Ca
2+ ﬂuorescence response, thus allowing an appropriate correspondence with the
subsequently recorded electrophysiology. The voltage clamp response was recorded at  70mV. The sharp event is likely to be a
breakthrough action potential. The current clamp recording was made with a small (8pA) hyperpolarizing holding current to keep the
baseline Em at  70mV. Note the different decay rates of the current, the membrane potential and the Ca
2+ dye ﬂuorescence signal [since
this greatly exceeds the decay in other preparations (Trevelyan et al., 2006), this is presumed to reﬂect the cytosolic concentration]. The
responses shown were from a cell with a severe mitochondrial deﬁcit. (D) Photomicrograph showing a cluster of neurons loaded with the
Ca
2+ dye, OGB1 (epi-ﬂuorescence illumination and with low light transillumination). The pipette (at 7 o’clock) contains 1mM glutamate in
artiﬁcial CSF, from which brief pulses of glutamate are delivered on to the cultured neurons. (E) The same ﬁeld viewed using differential
interference microscopy, and also showing a patch pipette (5 o’clock) onto one of the OGB labelled neurons seem in D.( F) Change in
ﬂuorescence  25mm in front of the picospritzing pipette when ﬁlled with a dilute concentration of rhodamine. This allows a visualization
of the time course of the local glutamate concentration in these picospritzing experiments. Pulses were delivered at 2s intervals for this
visualization, although the cell behaviour was studied using lower frequency stimuli. (G) Pulsatile Ca
2+ ﬂuorescence in response to a 0.1Hz
train of glutamate applications.
Table 1 Kinetics of ﬂuorescence signal in response to single transient glutamate stimuli in different cell lines
Cell lines Ca
2+ dye n 10–90% rise time  decay
Mean SD (s) Mean SD (s)
Control
ES-I Parental line OGB1 8 1.34 0.87 7.27 1.98
ES-I Parental line OGB2 12 1.05 0.36 6.05 4.74
Cy1-I Control polymorphism OGB1 5 0.81 0.32 4.52 1.73
Mutant
Cy2-I Mild deﬁcit OGB1 21 0.92 0.50 5.73 2.66
Cy3-I Severe deﬁcit OGB1 11 1.06 0.56 6.04 1.81
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transients to be signiﬁcantly slower [ decay for short loading
(30mins)=3.08 0.20s (avg SEM, n=21); long
loading (41h)=4.38 0.25s (n=17); ts=4.16, P50.001]
(Supplementary Fig. S3). Notably though, when the loading
protocol was standardized, the various cell lines showed no signif-
icant difference in the ﬂuorescence kinetics in response to a single
glutamate stimulus (Fig. 3, Table 1).
Since fatigue is a well-established feature of mitochondrial dis-
ease, we therefore examined how repeated stimuli affected the
time course of the Ca
2+ transients. To do this, we ﬁrst imaged the
response to a single puff of glutamate, and then after a pause for
recovery of 2–5mins, we delivered a train of glutamate puffs
(same ﬁeld of view and location of puffer pipette). We limited
our analysis to cells that showed 55% variation in the response
to the initial glutamate puff (Fig. 4), and a consistent pattern of
change of responses to all subsequent puffs in the train [whether
this be steady (e.g. Fig. 4A), incremental (e.g. Fig. 4B) or decre-
mental signals]. The rationale for these tight selection criteria was
to isolate consistent progressive changes induced by repeated
stimuli.
A striking feature of the control cell lines (ES-I and Cy1-I) was
that consecutive transients in the train routinely matched the initial
transient very well (Fig. 4A). The slow decay of the transients
meant that the subsequent stimuli occur before the ﬂuorescence
returned to baseline, and yet these cells did not show simple sum-
mation of events, but rather the response appeared to be capped
(cells which were distant from the glutamate electrode did
sometimes show summation, albeit from small and variable ampli-
tude, initial events).
Importantly, this apparent cap was not caused by saturation of
the dye, as shown by several experiments (Supplementary Figs S2
and S3). In short, the uniformity of successive ﬂuorescence signals
in the train was also seen using OGB2 (Supplementary Fig. S2A), a
variant of OGB1 with a much higher KD (Haughland, 2005).
Moreover, increasing the OGB1 buffer concentration, by extend-
ing the loading time (41h loading), did not alter the relative decay
rates after singlets and trains (i.e. it slowed the decays after both
patterns of stimulation equivalently; Supplementary Fig. S3). These
results also show that the apparent reproducibility of responses
was not inﬂuenced by the basal occupancy of the dye, since
this will be different for OGB1 and OGB2, or if the dye concen-
tration is increased. Furthermore, a rapid application of the calcium
Figure 3 Mitochondrial mutations do not affect the Ca
2+
transient in response to isolated, brief glutamate applications.
Sample traces of OGB1 ﬂuorescence in response to a single brief
glutamate application in a control cell line (ES-I) (A) and the cell
line with severe mitochondrial mutation (Cy3-I) (B). (C) Pooled
average responses in all four cell lines examined (n is the number
of different cells for each line).
Figure 2 Ca
2+ entry through NMDA and voltage-gated Ca
2+
channels. Ca
2+ ﬂuorescence in ES-I cells in response to a 3 pulse
train of glutamate picospritz pulses (0.33Hz), normalized to
the initial control response. Pharmacology measures were
only taken for cells which had a constant control response
(510% variation over 3 repeats). The pharmacological agents
were bath applied, as described in the ‘Material and methods’
section.
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that produced by glutamatergic stimuli (Supplementary Fig. S4;
Supplementary Movies 4 and 5). The OGB1 ﬂuorescence signal
could also be increased beyond the apparent cap, by applying the
uncoupling agent, carbonyl cyanide-p-triﬂuoromethoxyphenylhy-
drazone (FCCP; data not shown), indicating a possible role for
mitochondria in capping the Ca
2+ transient. Further details of
these control experiments are provided in the supplementary
ﬁgure legends. Collectively, they show that the striking feature
of the normal cybrid population, in which repeated stimuli produce
identical Ca
2+ transients, is likely to reﬂect accurately the pattern
of cytosolic Ca
2+.
In contrast with the singlet responses, there were marked
differences between the various cell lines in the responses to
trains of glutamate puffs (Figs 4 and 5). Cell lines with impaired
mitochondrial function (Cy2-I and Cy3-I) showed a progressive
deviation of the response to successive stimuli (Fig. 4B). To analyse
this further, we derived ‘residual’ traces (Fig. 4C), which represent
the difference between the decays of the nth transient in the train
and the time-shifted, singlet response. These residuals showed a
maximal deviation of the train decay from the singlet decay at
around 8–10s after the stimulus for cell lines with both mild
(Cy2-I) and severe (Cy3-I) mitochondrial dysfunction. The deviation
of decays was extremely protracted for Cy3-I (severe mutants),
being signiﬁcantly different 50s after the ﬁnal stimulus (Fig. 5B).
In other words, in cells with severe mitochondrial dysfunction, the
cytosolic Ca
2+ following a train of stimuli remains signiﬁcantly
above resting levels for tens of seconds after the stimulus ends.
The deﬁcit appears to be progressive, with a steady incremental
deviation for each successive stimulus in a train (Fig. 5C).
Figure 5 Cell lines with mutant mitochondria show altered Ca
2+ handling in response to repeated glutamate applications. (A) Average
‘residuals’ for the four different cell lines to show the alteration in decay kinetics when a cell with impaired mitochondrial function is
repeatedly stimulated (n is the number of different cells for each line). (B) Statistical comparisons at the two time points indicated by the
arrow heads in A.( C) The progressive change in kinetics in a mutated cell line, as measured 8s after each successive stimulus in a train of
ten pulses. Data are shown only for the ES-I (parental control) and for the Cy3-I (severe mutant) lines (error bars are the SEM of the
residual measures for each cell; parental, n=9; severe, n=7).
Figure 4 Progressive distortion of the Ca
2+ transient during a train of glutamate pulses, in cells with severe mitochondrial dysfunction.
(A) Overlays of the Ca
2+ ﬂuorescence in response to a single glutamate application and to a short train of applications in the parental
cell line, ES-I. The single application (‘singlet’) response is duplicated and time shifted (black trace) to overlay the ﬁnal response in the train.
The ﬁnal response in the train typically shows the same decay kinetics in control cell lines. These analyses were only performed for
cells which showed identical initial responses (52% variability). (B) Similar traces for Cy3-I, the cell line with a severe mitochondrial
deﬁcit. Note the marked deviation of the decay of the train relative to that of the singlet. (C) A ‘residual’ trace is calculated simply
by subtracting the singlet response from the ﬁnal response in the train. The example shows the derivation for the traces in panel B
(Cy3-I line).
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We present here data that show a progressive Ca
2+-handling def-
icit in neurons with pathogenic mtDNA mutations. To show this,
we used cybrid cell lines, which allow a direct comparison of the
effects on the cell biology of different mitochondrial genotypes
since the somatic genotype is constant. We mimicked synaptic
activation with very brief (tens of milliseconds) applications of
physiological concentrations of glutamate, and restricted our anal-
yses to cells which showed highly stable (55% difference) Ca
2+
responses to the initial stimulus in a train. By making this restric-
tion, we revealed a striking feature of Ca
2+ handling in the control
cell lines, which was that the initial event was exactly reproduced
following each stimulus in a train of stimuli. In contrast, cells with
mtDNA mutations showed normal responses to a single glutamate
application, but the response to subsequent applications became
increasingly distorted. We suggest that this represents a novel
form of cellular fatigue in cells with impaired oxidative
phosphorylation.
Ca
2+ handling in wild-type neurons
The electrophysiological responses to glutamate are reasonably
stable when stimuli are presented at 0.1Hz, and in control cells,
this is reﬂected in the normalized pattern of Ca
2+ transient. The
stability of the Ca
2+ transient has some noteworthy features. The
long decay means that, if stimulated at 0.1Hz, the Ca
2+ level is
still markedly raised at the start of the next transient. As such, one
might expect summation of events, and indeed this does occur if
the initial transient is small, as happens far from the glutamate
pipette. Other cells, typically close to the glutamate pipette,
show large amplitude and very stable initial responses, and in
these cells there is no summation; rather, the amplitudes of suc-
cessive peaks are constant, and since the decay is also stable, the
entire shape of the event is reproduced.
The conventional view of Ca
2+ cycling in neurons is that mito-
chondria rapidly absorb most of the Ca
2+ which enters the cells
when cytosolic Ca
2+ concentration exceeds a threshold value of
around 0.8mM (Nicholls, 1978). This threshold for mitochondrial
uptake is a powerful means of producing a cytosolic Ca
2+ cap
because as the cytosolic Ca
2+ levels rise and once the threshold
for mitochondrial uptake is surpassed, there is a great acceleration
in the rate of Ca
2+ clearance from the cytosol. This will produce a
relatively stable capping effect over a range of Ca
2+ inﬂux param-
eters. Mitochondrial uptake is dependent on the large electroche-
mical potential generated across the inner mitochondrial
membrane by the electron transfer chain. Ca
2+ entry rapidly dis-
sipates the electrochemical gradient, and thus diminishes the driv-
ing force for Ca
2+ uptake, but also stimulates the recovery process
by activating various mitochondrial metabolic pathways. The mito-
chondria thus greatly curtail the initial cytosolic transient, but then
Ca
2+ is returned to the cytosol over a much longer period as part
of the process of recycling the cation to the extracellular space
(Fierro et al., 1998).
Altered Ca
2+-handling phenotype
associated with mitochondrial
mutations
In both mutant cell lines, the response to an isolated glutamate
application was no different from controls for all measures (peak
F/F, 10–90% rise time, decay time constants). Our experimental
protocol did not permit an estimate of baseline cytosolic Ca
2+
levels (which requires ratiometric imaging), but the similarity of
the ‘singlet’ response to control responses strongly suggests that
baseline Ca
2+ regulation in the mutant cells was ostensibly normal.
In contrast to the normal cell lines, however, the responses to
successive stimuli were not maintained; there was a progressive
small increase in the peak ﬂuorescence, peak on peak, and a
marked slowing of the decay. Moreover, the Ca
2+-handling deﬁcit
is more severe in those neurons showing the greatest reduction in
oxidative phosphorylation capacity, consistent with a direct causal
link between the genetic deﬁcit and the Ca
2+-handling phenotype.
It is worth considering these changes in terms of the single
compartment model of Ca
2+ ﬂuxes proposed by Neher and
Augustine (1992). In their formulation, the time constant of the
ﬂuorescence decay,  , can be written as a function of the buffer-
ing capacities (J) of the exogenous buffer (namely the Ca
2+ dye;
sufﬁx ‘e’) and endogenous buffer (sufﬁx ‘b’), and the plasmalem-
mal clearance rate,  , as follows:
  ¼ð 1 þ Ke þ KbÞ= 
to produce the requisite change during the train of stimuli, there
would have to be either an acute increase in the buffering capa-
cities of the cell (endogenous or exogenous buffering), or an acute
reduction in the clearance rate. It is difﬁcult to envisage though,
how a mitochondrial mutation may allow an acute increase in
buffering; if anything, the opposite might be expected. Nor is it
likely that other endogenous buffering systems could be liberated
over this acute time course, although we cannot rule this out
(a chronic increase in Ca
2+ buffering capacity might be expected
as an adaptive response, although the ‘normal’ decays of the
singlet Ca
2+ transients provide no evidence of such a change).
Far more likely is that the reduced oxidative phosphorylation in
these cells causes a deﬁcit in ATP, and thereby compromises the
clearance of Ca
2+ through Ca
2+-ATPases. A reduced rate of clear-
ance would also be expected to cause the small upward shift in
the apparent Ca
2+ cap seen in these neurons. Note though, that
this increase in the peak is still less than expected from simple
summation for events with a time constant, 6s (expected increase
 20%) indicative that the cap still exists in these cells, albeit in a
compromised state.
Thus, our data suggest that baseline Ca
2+ regulation is appar-
ently well maintained, but there is a rapid loss of the ability to
regulate cytosolic Ca
2+ concentration when the system is strained,
which may have long-lasting consequences. This observation
would ﬁt with previous studies, which show that even in the pres-
ence of a mitochondrial respiratory chain defect, ATP levels within
the cell and the mitochondrial membrane potential are maintained
under resting conditions (von Kleist-Retzow et al., 2007). ATP can
be generated by glycolysis, and this ATP may also be used to
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essential for maintaining cell viability (Campanella et al., 2008;
Abramov et al., 2010). With repetitive stimulation, the ability to
maintain ATP levels will be impaired (Taylor et al., 1994) without
effective oxidative phosphorylation and thus be likely to result in
altered Ca
2+ regulation.
The consequences of Ca
2+ dysregulation
The consequences of this altered Ca
2+ regulation are likely to be
manifold. Ca
2+ occupies a pivotal role coordinating many different
molecular cascades in all cell types, over many different timescales
(Berridge et al., 2003). In neurons, ﬂuxes in cytosolic Ca
2+ con-
centration coordinate transmitter release, long-term potentiation
and long-term depression, dendritic spine remodelling, develop-
mental remodelling of dendritic and axonal branches, regulation
of gene expression and entry into different cell death pathways. It
is believed that the exact temporal and spatial extent of the tran-
sient Ca
2+ elevation explains how this single ionic species can
coordinate these disparate pathways. For instance, both long-term
potentiation and long-term depression have been shown to
require Ca
2+ entry through NMDA receptors at a dendritic spine,
but the exact timing of the entry relative to the timing of a
post-synaptic action potential and the associated Ca
2+ elevation
in the dendrite adjacent to the spine determines which of these
two processes occurs. If the kinetics of the Ca
2+ transient are
altered by dysfunctional mitochondria, then the speciﬁcity of the
Ca
2+ signal will be affected, leading to the activation of either the
wrong molecular cascade, or of multiple cascades in multiple spa-
tial locations. These mtDNA mutations may also affect mitochon-
drial movement and distribution around the cell, with further
consequences for local Ca
2+ regulation (Kang et al., 2008). The
pathological distortion of the Ca
2+ signal may be expected to
affect brain function, even without ostensible neuronal loss. This
functional pathology will of course be further exacerbated by neu-
ronal cell death caused by dysregulation.
These ﬁndings are relevant to the clinical features of mtDNA
disease. In these patients, there is often development of symptoms
related to neurodegeneration later in life, which is supportive of
the relatively subtle changes seen in Ca
2+ dysregulation
(McFarland et al., 2002). In addition, there is often deterioration
in patients following epileptic seizures (Okumura et al., 2008), a
situation in which intense neuronal activity is associated with
extreme cytosolic Ca
2+ loading (Trevelyan et al., 2006). This
raises issues in terms of management of patients with mitochon-
drial disease, especially at times of seizures. Aborting the seizure as
quickly as possible is clearly crucial, but we should consider the
possibility of interventions that might also limit toxicity due to high
intracellular Ca
2+.
In conclusion, we show here for the ﬁrst time, a change in Ca
2+
handling in neurons that arises as a direct consequence of muta-
tions in the mitochondrial genome. Although we are still far from
achieving a complete understanding of the consequences of such
mutations, our results give insight into many facets of mitochon-
drial disease by showing that neuronal dysfunction may only be
apparent with repetitive stimulation, and that a key feature is a
progressive distortion of Ca
2+ signalling with widespread conse-
quences for neuronal development, communication and cell death.
Funding
The Wellcome Trust, Wolfson Foundation Marriott Foundation
and Newcastle Centre for Brain Ageing and Vitality (supported
by Biotechnology and Biological Sciences Research Council,
Engineering and Physical Sciences Research Council, Economic
and Social Research Council and Medical Research Council).
Australian National Health and Medical Research Council
(NHMRC) CJ Martin Postdoctoral Fellowship (to D.M.K.). A.J.T
currently holds an Epilepsy Research UK Fellowship.
Supplementary material
Supplementary material is available at Brain online.
References
Abramov AY, Smulders-Srinivasan TK, Kirby DM, Acin-Perez R,
E ´nriquez JA, Lightowlers RN, et al. Mechanism of neurodegeneration
of neurons with mitochondrial DNA mutations. Brain 2010, in press.
Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem
cells express neuronal properties in vitro. Dev Biol 1995; 168: 342–57.
Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH,
et al. High levels of mitochondrial DNA deletions in substantia nigra
neurons in aging and Parkinson disease. Nat Genet 2006; 38: 515–7.
Bender A, Schwarzkopf RM, McMillan A, Krishnan KJ, Rieder G,
Neumann M, et al. Dopaminergic midbrain neurons are the prime
target for mitochondrial DNA deletions. J Neurol 2008; 255: 1231–5.
Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics,
homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517–29.
Brini M, Pinton P, King MP, Davidson M, Schon EA, Rizzuto R. A calcium
signaling defect in the pathogenesis of a mitochondrial DNA inherited
oxidative phosphorylation deﬁciency. Nat Med 1999; 5: 951–4.
Campanella M, Casswell E, Chong S, Farah Z, Wieckowski MR,
Abramov AY, et al. Regulation of mitochondrial structure and function
by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab 2008; 8: 13–25.
Carafoli E, Rossi CS, Lehninger AL. Cation and anion balance during
active accumulation of Ca
++ and Mg
++ by isolated mitochondria. J
Biol Chem 1964; 239: 3055–61.
Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML,
et al. Thymocyte apoptosis induced by p53-dependent and indepen-
dent pathways. Nature 1993; 362: 849–52.
Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL. The time
course of glutamate in the synaptic cleft. Science 1992; 258:
1498–501.
Crompton M, Moser R, Ludi H, Carafoli E. The interrelations between
the transport of sodium and calcium in mitochondria of various mam-
malian tissues. Eur J Biochem 1978; 82: 25–31.
DiMauro S, Davidzon G. Mitochondrial DNA and disease. Ann Med
2005; 37: 222–32.
DiMauro S, Schon EA. Mitochondrial disorders in the nervous system.
Annu Rev Neurosci 2008; 31: 91–123.
Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic
mitochondrial DNA mutations are common in the general population.
Am J Hum Genet 2008; 83: 254–60.
Fan W, Waymire KG, Narula N, Li P, Rocher C, Coskun PE, et al. A
mouse model of mitochondrial disease reveals germline selection
against severe mtDNA mutations. Science 2008; 319: 958–62.
Mitochondrial mutations affect Ca2+ handling Brain 2010: 133; 787–796 | 795Fierro L, DiPolo R, Llano I. Intracellular calcium clearance in Purkinje
cell somata from rat cerebellar slices. J Physiol 1998; 510 (Pt 2):
499–512.
Glitsch MD, Bakowski D, Parekh AB. Store-operated Ca
2+ entry depends
on mitochondrial Ca
2+ uptake. EMBO J 2002; 21: 6744–54.
Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose
synaptic NMDARs by triggering CREB shut-off and cell death path-
ways. Nat Neurosci 2002; 5: 405–14.
Haughland RP. The Handbook: A guide to ﬂuorescent probes and label-
ling techniques. USA: Invitrogen Corporation; 2005.
Hille B. Ionic channels of excitable membranes. Sunderland, MA: Sinauer
Associates; 2002.
Kang JS, Tian JH, Pan PY, Zald P, Li C, Deng C, et al. Docking of axonal
mitochondria by syntaphilin controls their mobility and affects short-
term facilitation. Cell 2008; 132: 137–48.
Kirby DM, Rennie KJ, Smulders-Srinivasan TK, Acin-Perez R,
Whittington M, Enriquez JA, et al. Transmitochondrial embryonic
stem cells containing pathogenic mtDNA mutations are compromised
in neuronal differentiation. Cell Prolif 2009; 42: 413–24.
Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW,
Khrapko K. Mitochondrial DNA deletions are abundant and cause
functional impairment in aged human substantia nigra neurons. Nat
Genet 2006; 38: 518–20.
McFarland R, Taylor RW, Turnbull DM. The neurology of mitochondrial
DNA disease. Lancet Neurol 2002; 1: 343–51.
McFarland R, Taylor RW, Turnbull DM. Mitochondrial disease–its impact,
etiology, and pathology. Curr Top Dev Biol 2007; 77: 113–55.
Mitchell P, Moyle J. Chemiosmotic hypothesis of oxidative phosphoryla-
tion. Nature 1967; 213: 137–9.
Moudy AM, Handran SD, Goldberg MP, Rufﬁn N, Karl I, Kranz-Eble P,
et al. Abnormal calcium homeostasis and mitochondrial polarization in
a human encephalomyopathy. Proc Natl Acad Sci USA 1995; 92:
729–33.
Neher E, Augustine GJ. Calcium gradients and buffers in bovine chro-
mafﬁn cells. J Physiol 1992; 450: 273–301.
Nicholls DG. The regulation of extramitochondrial free calcium
ion concentration by rat liver mitochondria. Biochem J 1978; 176:
463–74.
Nishiyama M, Hong K, Mikoshiba K, Poo MM, Kato K. Calcium stores
regulate the polarity and input speciﬁcity of synaptic modiﬁcation.
Nature 2000; 408: 584–8.
Okumura A, Kidokoro H, Itomi K, Maruyama K, Kubota T, Kondo Y,
et al. Subacute encephalopathy: clinical features, laboratory data, neu-
roimaging, and outcomes. Pediatr Neurol 2008; 38: 111–7.
Parekh AB. Store-operated Ca
2+ entry: dynamic interplay between
endoplasmic reticulum, mitochondria and plasma membrane.
J Physiol 2003; 547: 333–48.
Parekh AB. Mitochondrial regulation of store-operated CRAC channels.
Cell Calcium 2008; 44: 6–13.
Sabatini BL, Oertner TG, Svoboda K. The life cycle of Ca
(2+) ions in
dendritic spines. Neuron 2002; 33: 439–52.
Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW,
et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol
2008; 63: 35–9.
Sparaco M, Bonilla E, DiMauro S, Powers JM. Neuropathology of mito-
chondrial encephalomyopathies due to mitochondrial DNA defects.
J Neuropathol Exp Neurol 1993; 52: 1–10.
Taylor DJ, Kemp GJ, Radda GK. Bioenergetics of skeletal muscle in mito-
chondrial myopathy. J Neurol Sci 1994; 127: 198–206.
Trevelyan AJ, Sussillo D, Watson BO, Yuste R. Modular propagation of
epileptiform activity: evidence for an inhibitory veto in neocortex.
J Neurosci 2006; 26: 12447–55.
Vasington FD, Murphy JV. Ca ion uptake by rat kidney mitochondria and
its dependence on respiration and phosphorylation. J Biol Chem 1962;
237: 2670–7.
Visch HJ, Koopman WJ, Zeegers D, van Emst-de Vries SE, van
Kuppeveld FJ, van den Heuvel LW, et al. Ca
2+-mobilizing agonists
increase mitochondrial ATP production to accelerate cytosolic Ca
2+
removal: aberrations in human complex I deﬁciency. Am J Physiol
Cell Physiol 2006; 291: C308–16.
Visch HJ, Rutter GA, Koopman WJ, Koenderink JB, Verkaart S, de
Groot T, et al. Inhibition of mitochondrial Na
+-Ca
2+ exchange restores
agonist-induced ATP production and Ca
2+ handling in human complex
I deﬁciency. J Biol Chem 2004; 279: 40328–36.
von Kleist-Retzow JC, Hornig-Do HT, Schauen M, Eckertz S, Dinh TA,
Stassen F, et al. Impaired mitochondrial Ca
2+ homeostasis in respira-
tory chain-deﬁcient cells but efﬁcient compensation of energetic dis-
advantage by enhanced anaerobic glycolysis due to low ATP steady
state levels. Exp Cell Res 2007; 313: 3076–89.
Werth JL, Thayer SA. Mitochondria buffer physiological calcium loads in
cultured rat dorsal root ganglion neurons. J Neurosci 1994; 14:
348–56.
Willems PH, Valsecchi F, Distelmaier F, Verkaart S, Visch HJ, Smeitink JA,
et al. Mitochondrial Ca
2+ homeostasis in human NADH:ubiquinone
oxidoreductase deﬁciency. Cell Calcium 2008; 44: 123–33.
Ying QL, Stavridis M, Grifﬁths D, Li M, Smith A. Conversion of embryo-
nic stem cells into neuroectodermal precursors in adherent monocul-
ture. Nat Biotechnol 2003; 21: 183–6.
796 | Brain 2010: 133; 787–796 A. J. Trevelyan et al.